Research Journal of Health Sciences https://www.ajol.info/index.php/rejhs <p>The <em>Research Journal of Health Sciences</em> is dedicated to promoting high quality research work in the field of health and related biological sciences. It aligns with the mission of the Osun State University, which is “to create a unique institution, committed to the pursuit of academic innovation, skills-based training and a tradition of excellence in teaching, research and community service”. The Journal acts as a medium of improving the quality of health care and medical education particularly in the context of developing countries with limited resources.</p> <p>The <em>Research Journal of Health Sciences</em> aim to make a substantial contribution towards providing high quality publications in health sciences and related biological sciences. It publishes manuscripts from basic and clinical sciences that have not been submitted for publication/or under consideration for publication elsewhere. The Journal ensures a rigorous review process.</p> <p>Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (<a href="http://creativecommons.org/licences/by-nc-nd/4.0">http://creativecommons.org/licences/by-nc-nd/4.0</a>). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.</p> en-US <h3>By submitting manuscripts to RJHS authors of original articles are assigning copyright to the College of Health Sciences, Osun State University. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in RJHS for educational and research purposes without obtaining permission.</h3><p>CREATIVE COMMONS ATTRIBUTION-NONCOMMERCIAL-NODERIVATIVES 4.0 INTERNATIONAL PUBLIC LICENSE By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions. Section 1 – Definitions. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license. Licensor means the individual(s) or entity(ies) granting rights under this Public License. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning. Section 2 – Scope. License grant. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to: reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and produce and reproduce, but not Share, Adapted Material for NonCommercial purposes only. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions. Term. The term of this Public License is specified in Section 6(a). Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material. Downstream recipients. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i). Other rights. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise. Patent and trademark rights are not licensed under this Public License. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes. Section 3 – License Conditions. Your exercise of the Licensed Rights is expressly made subject to the following conditions. Attribution. If You Share the Licensed Material, You must: retain the following if it is supplied by the Licensor with the Licensed Material: identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated); a copyright notice; a notice that refers to this Public License; a notice that refers to the disclaimer of warranties; a URI or hyperlink to the Licensed Material to the extent reasonably practicable; indicate if You modified the Licensed Material and retain an indication of any previous modifications; and indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License. For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable. Section 4 – Sui Generis Database Rights. Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material: for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only and provided You do not Share Adapted Material; if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database. For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights. Section 5 – Disclaimer of Warranties and Limitation of Liability. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability. Section 6 – Term and Termination. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates: automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or upon express reinstatement by the Licensor. For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License. Sections 1, 5, 6, 7, and 8 survive termination of this Public License. Section 7 – Other Terms and Conditions. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License. Section 8 – Interpretation. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.</p> editor.rjhs@uniosun.edu.ng (Professor Alebiosu C.O. BSc, MBChB, FWACP) deskeditor2.rjhs@uniosun.edu.ng (Dr Atere M.A, MPhil) Mon, 12 Aug 2024 15:21:06 +0000 OJS 3.3.0.11 http://blogs.law.harvard.edu/tech/rss 60 An Unusual presentation of Cutaneous Sarcoidosis in a Nigerian: A case report https://www.ajol.info/index.php/rejhs/article/view/276083 <p><strong>Background</strong>: Sarcoidosis is an idiopathic disorder which present with different manifestation. This is an unusual case of cutaneous&nbsp; sarcoidosis with extensive polymorphic lesions on the skin as the only organ involved.</p> <p><strong>Case Report</strong>: Mrs. A.O, a 28 year old house-wife presented with a one year history of progressive itchy, reddish, raised skin rashes for one&nbsp; year. Lesions were initially localized to the chest and limbs but subsequently involved the whole body including the palms and soles.&nbsp; No history of fever or weight loss. On examination, she had generalized erythematous, annular and arcuate plaques with areas of active&nbsp; edges involving the whole body including the palms and soles. Healed lesions were atrophic and hyperpigmented (Figure 1). No mucosal&nbsp; involvement. Her chest radiograph, FBC, ESR, LFT, serum Calcium, ACE levels (20U/L) and ECG were normal, while her Mantoux and Gene&nbsp; expert test was negative. Biopsy of the lesion showed dermal infiltrates, composed of epithelioid histocytes disposed in nodules as well&nbsp; as multinucleated giant cells of langhans and foreign body types features consistent with cutaneous annular sarcoidosis (Figure 3 and 4).&nbsp; She was placed on systemic steroids followed by topical steroids and made significant improvement. (figure 2)</p> <p><strong>Conclusion</strong>: Sarcoidosis is&nbsp; not common in our environment and cutaneous manifestation as the sole presentation is even rarer. We report one such case with skin&nbsp; as the sole organ affected and equally of interest is the extensive nature of the lesions observed.&nbsp;</p> H. Sani Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276083 Mon, 12 Aug 2024 00:00:00 +0000 Screening for chronic kidney disease among health workers in a tertiary hospital in North Central Nigeria https://www.ajol.info/index.php/rejhs/article/view/276084 <p><strong>Background:</strong> Screening adults for chronic kidney disease and managing those identified has been advocated as one of the means of&nbsp; limiting the burden of the disease. The renal study team of Federal Medical Centre, Bida decided to screen health workers in the hospital&nbsp; for chronic kidney disease as part of activities marking the world kidney day.</p> <p><strong>Methods</strong>: A purposive cross-sectional study involving 262&nbsp; health workers; using self -administered questionnaire was carried out after adequate publicity. Chronic kidney disease was defined&nbsp; according to KDIGO. Data obtained were analyzed with SPSS version 21.2</p> <p><strong>Results</strong>: Chronic kidney disease defined as eGFR &lt;60mls/ min/1.73m was seen in 19 (7.25%) of the respondents. Also 79 (30.15%) had eGFR spanning within 2 60 – 89mls/min/1.73m . Marital status&nbsp; and recurrent body swelling were significantly associated with chronic kidney disease (p= 0.018 and 0.045 respectively). Marital&nbsp; status was the only predictor of chronic kidney disease in the population (p=0.047, Exp B= 0.166, CI= 0.028 – 0.976).</p> <p><strong>Conclusion</strong>: We&nbsp; advocate that comprehensive renal function test should be included in pre-employment medical screening test in the country.&nbsp;</p> A. Bello, C. Oladele , O. Akinola , R. Dashe , S. Ajimuda, A. Abdulmalik, M. Mohammad , A. Mohammed, O. Olaosebikan , A. Adekanye , L. Uzoigwe , S. Aiyedun , S. Aiyedun , B. Rotimi , U. Abubakar Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276084 Mon, 12 Aug 2024 00:00:00 +0000 Prevention of post-anaesthetic shivering under subarachnoid block for lower limb surgeries: A randomised controlled study comparing nefopam and tramadol https://www.ajol.info/index.php/rejhs/article/view/276086 <p><strong>Objectives</strong>: Shivering is one of the frequent, undesirable and unpleasant effects of spinal anaesthesia that can be prevented by several&nbsp; means including, pharmacological and non-pharmacological methods.</p> <p><strong>Methods</strong>: Patients between 18 and 65 years were randomly assigned into two groups (A or B). Group A patients received intravenous&nbsp; 0.3mg/kg nefopam while Group B patients received intravenous 0.5mg/kg tramadol just before the institution of subarachnoid block. The&nbsp; parameters assessed were: the incidence of post-spinal anaesthetic shivering, its' severity, and the side-effects of the two drugs.&nbsp; Changes in haemodynamic parameters, temperature, peripheral arterial oxygen saturation and temperature were also evaluated.</p> <p><strong>Results</strong>: Thirty- four patients (100%) in group A and twenty-eight patients (82.35%) in group B, were shivering-free. Thus, only six patients&nbsp; (17.65%) in Group B shivered intra-operatively; p= 0.025, which is statistically significant. The severity of post-anaesthetic&nbsp; shivering was assessed to be grade 2 in three patients (8.82%), while it was grade 1 in the remaining three patients (8.82%). Four patients&nbsp; experienced nausea in group B, but none in group A; p = 0.114 No episode of vomiting was observed in both groups.</p> <p><strong>Conclusion</strong>:&nbsp; Nefopam is better than tramadol for the prevention of intraoperative shivering under spinal anaesthesia.&nbsp;</p> R.O. Shoyemi , O.M. Fatungase, O.A. Soyannwo , S.O. Olateju , E.A. Emmanuel , L.O. Thanni, E.O. Elegbe Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276086 Mon, 12 Aug 2024 00:00:00 +0000 Geo-Biochemical properties of peroxidase extracted from <i>Cola nitida</i> At the Ninth Year of Planting https://www.ajol.info/index.php/rejhs/article/view/276087 <p><strong>Background</strong>: This study reports the biochemical properties of plant peroxidase from white cultivars of <em>Cola nitida</em> for sustained&nbsp; biotechnological applications.</p> <p><strong>Methods</strong>: Peroxidase was extracted from <em>Cola nitida</em>, in 20 mM sodium phosphate buffer pH 7.0 containing 10% glycerol, 1% PEG, ,&nbsp; 0.015% citric acid, 0.010% L-Cysteine and 0.010% ascorbic acid Buffer C). The extracted peroxide was subjected to a step wise purification&nbsp; stages which separated it into two peaks. The native molecular weight was determined for the major peak to be 21 ± 1.16 kDa while the&nbsp; subunit was estimated to be 15.5 ± 2.1 kDa.</p> <p><strong>Results</strong>: Optimum pH and temperature was studied to be 4.0 and 40<sup>o</sup>C respectively. Further&nbsp; studies required investigating several methods of immobilization on the nine years harvested Cola nitida in order to enhance its biotechnological applications.</p> <p><strong>Conclusion</strong>: However, this study was able to establish that Cola nitida is a strong alternative to the&nbsp; commonly purchased horseradish peroxidase.&nbsp;</p> O.A. Adefila , K.F. Akinloye Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276087 Mon, 12 Aug 2024 00:00:00 +0000 Platelet count can be used to determine the severity of oesophageal varices https://www.ajol.info/index.php/rejhs/article/view/276088 <p><strong>Introduction</strong>: Variceal haemorrhage is one of the most devastating consequences of portal hypertension. The risk of bleeding increases&nbsp; with severity of varices. It is important to see if there are parameters that can noninvasively predict severity of varices as endoscopy has&nbsp; some limitations.</p> <p><strong>Aims and Objectives</strong>: This study sought to determine if platelet count can be used to determine the severity of oesophageal varices in a&nbsp; low resource setting.</p> <p><strong>Methodology</strong>: This was a descriptive cross-sectional study, in which 79 patients with chronic liver disease and upper&nbsp; gastrointestinal endoscopy diagnosed varices were recruited consecutively to participate in the study. Blood sample for platelet&nbsp; count was taken from each patient. A proforma was used to document the demographic parameters as well as grade of varices and&nbsp; platelet count. The ability of platelet count to determine severity of oesophageal varices was assessed. Test of association between&nbsp; platelet count groups and grades of varices was carried out using the Chi-Square Test. Test of correlation between platelet count and&nbsp; grades of varices was carried out using the Spearman's coefficient.</p> <p><strong>Result</strong>: A total of 79 subjects were recruited into the study. Test of&nbsp; correlation between platelet count and grades of varices was statistically significant (ñ value: -0.783; p value: 0.001. There was a&nbsp; statistically significant difference in the median platelet count and grade of varices (p=&lt;0.0001).</p> <p><strong>Conclusion</strong>: Platelet count, a simple,&nbsp; cheap and available investigation, can be used as a non-invasive predictor of severity of varices in resource poor settings with limited&nbsp; endoscopy services.&nbsp;</p> K.C. Okonkwo , A.B. Olokoba , O.M. Bojuwoye , A.M. Aliyu Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276088 Mon, 12 Aug 2024 00:00:00 +0000 Trichoscopy findings of normal scalp and hair in blacks - A community survey https://www.ajol.info/index.php/rejhs/article/view/276089 <p><strong>Background</strong>: Trichoscopic features of scalp and hair diseases have been described in Caucasians, Asians, Hispanics, and Black Americans&nbsp; but few reported in Nigerians. A survey of trichoscopic findings on disease-free scalp and hair of Black Africans becomes relevant and&nbsp; forms a comparative basis for establishing findings in a diseased state.<br><strong>Objective</strong>: To examine the scalp and hair of Nigerians in a semi-urban community with no scalp and/or hair disease and document&nbsp; trichoscopy findings.<br><strong>Method</strong>: A cross-sectional descriptive survey of 307 individuals at a semiurban market in Lagos where the scalp and hair of all&nbsp; participants were reviewed clinically and using DermLite® dermscope by dermatologists. Demographic data, clinical and trichoscopic&nbsp; findings of participants with no scalp or hair disease were documented using a pre-designed questionnaire. Data was analysed using IBM SPSS version 22. Ethical approval was sought and obtained from the Lagos State University Teaching Hospital (LREC/06/10/1297).<br><strong>Result</strong>: 96 (31.3%) participants had normal hair M:F ratio of 1.1:1.0 . Those aged between 35 – 39 years and &lt;25 years age bracket was&nbsp; 18.8% and 15.6% respectively. White dots were seen in (95; 99%), white dots with regular distribution (93; 96.9%), preserved honeycomb&nbsp; pattern in (92; 95.8%) and peripilar casts in 14; 14.6% of partcipants.<br><strong>Conclusion</strong>: Trichoscopic findings of normal scalp and hair in Black Africans include regular white dots and preserved honeycomb&nbsp; appearance. Peripilar casts and scales may also be seen in Africans without hair or scalp disease.</p> E. Otrofanowei , E.L. Anaba , A.O. Akinkugbe , O. Cole-Adeife, O.O. Ayanlowo, I. Akwara, R.I. Oaku Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276089 Mon, 12 Aug 2024 00:00:00 +0000 Indications and outcomes of induction of labour among induced women in a tertiary hospital in Southwest Nigeria: a five-year review https://www.ajol.info/index.php/rejhs/article/view/276090 <p><strong>Background</strong>: Induction of labour (IOL) is a common obstetric practice worldwide when the continuation of pregnancy poses a threat to&nbsp; the well-being of the mother or fetus.</p> <p><strong>Objectives</strong>: This study assessed the indications and outcome of labour induction among induced women in a tertiary hospital in&nbsp; Southwest Nigeria.</p> <p><strong>Method</strong>: A5-year review of records of all clients that had induction of labour at the facility between January 1, 2012, and December 31,&nbsp; 2016, was conducted, ® and analysis was done using IBM SPSSversion 23. Results were presented in tables and charts using frequencies&nbsp; and percentages. Chisquare test was used to assess for association between sociodemographic/obstetrics characteristics and the mode&nbsp; of delivery, with significance level(á) set at 0.05.</p> <p><strong>Results</strong>: A total of 286 women were induced during the period, with 79.0% successfully&nbsp; achieving vaginal delivery. Postdate pregnancy was the commonest 88 (30.6%) indication for IOL, and majority of 233 (81.5%) of the women had no complications.</p> <p><strong>Conclusion</strong>: The major indication for IOLin this study was postdate pregnancy, and the study observed a&nbsp; high success rate among women who had IOL, with very few reports of complications in both the mother and fetus.&nbsp;</p> M. Ayinde, M. Aliu-Ayinde, K.M. Owonikoko, A. Ahmed , M.A. Adeniyi, A.S. Azees Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276090 Mon, 12 Aug 2024 00:00:00 +0000 The predictors of ownership and utilization of Long-Lasting Insecticidal Nets among caregivers of under-five children in Ekiti State, South-West, Nigeria https://www.ajol.info/index.php/rejhs/article/view/276091 <p><strong>Background</strong> - Malaria is a life-threatening disease associated with a high level of morbidity and mortality in sub-Saharan Africa especially&nbsp; among children under five years of age. Long-lasting insecticidal Nets (LLINs) ownership and utilization are some of the&nbsp; proven interventions to reduce the burden of the disease. This paper aims to assess and compare the predictors of ownership and&nbsp; utilization of LLINs among caregivers of under-five children living in urban and rural settlements in Ekiti State, Nigeria. - This was a cross- sectional comparative study among 800 under-five caregivers. A multistage sampling technique selected 400 caregivers each from urban&nbsp; and rural settlements. Data were analyzed using Statistical Product and Service Solution (SPSS) IBM version 23. Univariate analysis was&nbsp; conducted to summarize the data and inferential statistics were generated using chisquare and binary logistic regression at 95%CI. The&nbsp; results showed much lower ownership rates in urban (32.3%) than the rural (33.0%). The predictor of ownership of LLINs among&nbsp; respondents in urban settlements was, obtaining their information about LLINs from health workers, friends as sources of information,&nbsp; awareness, good knowledge, and having positive attitudes about LLINs. Utilization is better in the rural (78.0%) compared to the urban&nbsp; (61.2%). The predictor of utilization of LLINs in urban settlements was having positive attitudes towards LLINs while the predictors of the&nbsp; utilization of LLINs in rural were the number of under-five children with caregivers and positive attitude to LLINs.</p> <p><strong>Conclusion</strong> –Ownership&nbsp; of LLINs in both settlements was very low and lagged in urban. The utilization was however higher but also lagged in urban.&nbsp; However, it has not reached the 80% proposed by the National Malaria Control Programme. It is therefore recommended that the Government and partners sustain the free distribution of LLINs throughout the year in the communities to improve ownership and Social&nbsp; and Behavioral Change Communication (SBCC) intervention is necessary to improve utilization.&nbsp;&nbsp;&nbsp;</p> O.P. Oluyide, O.O. Odu, S.K. Salami, O.O. Omoyele, F.F. Oyinlola, S.A. Deji, A. Usman, M. Balogun, E.A. Bamgboye Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276091 Mon, 12 Aug 2024 00:00:00 +0000 Pattern of co-morbidities in chronic kidney disease patients on haemodialysis in Delta State, Nigeria: a retrospective study https://www.ajol.info/index.php/rejhs/article/view/276092 <p><strong>Background</strong>: Chronic kidney disease is regarded as a significant cause of mortality and morbidity in this current century, with a&nbsp; prevalence rate ranging between 1.6% and 12.4% in Nigeria.</p> <p><strong>Objective</strong>: To identify the prevalence rates of the various co-morbidities in CKD patients undergoing haemodialysis in a private centre in&nbsp; Delta State, Nigeria.</p> <p><strong>Methods</strong>: This study is a 6-year retrospective study, which reviewed all records of chronic kidney disease patients who visited the private&nbsp; centre in Delta State from 2016 – 2021. The variables accessible and retrieved from the registry were: age, sex, and co-morbid conditions.&nbsp; Data obtained were entered and analysed using Microsoft Excel. Descriptive statistics were used to present the results.</p> <p><strong>Result</strong>: Of the&nbsp; 7490 patients who received care for chronic kidney disease within the period under review, 1940 patients had 7262 sessions of haemodialysis and were included in the study. The mean age of patients was 50.36±17.16. About 1222(63.7%) are males while 718(36.3%)&nbsp; are females. The prevalence rate of the various co-morbid conditions identified were: hypertension (96.1%), diabetes (67%), HIV (14.4%),&nbsp; Hepatitis C (8.8%), Hepatitis B (6.9%), and obesity (5.2%).</p> <p><strong>Conclusion</strong>: Majority of CKD patients present with various co-morbid conditions,&nbsp; with the most frequently occurring condition being hypertension. It is recommended that CKD patients should be evaluated&nbsp; for other conditions with increased likelihood of occurrence.&nbsp;</p> A.B. Odonmeta , N.S. Awunor, E.J. Uniamikogbo, E.C. Ucho Copyright (c) 2024 https://www.ajol.info/index.php/rejhs/article/view/276092 Mon, 12 Aug 2024 00:00:00 +0000